Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S P Richman

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
World Journal of Surgery|September 1, 1977
Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractionsM A Schwarz, J U Gutterman, E M Hersh, et al.
Cancer|September 15, 1992
Phase II trial of 4'-0-tetrahydropyranyladriamycin (pirarubicin) in head and neck carcinomaK S Sridhar, A M Hussein, P Benedetto, et al.
Cancer Treatment Reports|May 1, 1976
Chemotherapy versus chemoimmunotherapy of head and neck cancer: report of a randomized studyS P Richman, R B Livingston, J U Gutterman, et al.
Cancer Treatment Reports|May 1, 1977
Phase I study of immunotherapy with methanol extraction residue (MER) of bacillus Calmette-GuérinS P Richman, J U Gutterman, E M Hersh, et al.
Cancer|December 1, 1975
Successful control of systemic Aspergillus niger infections in two patients with acute leukemiaF G Gercovich, S P Richman, V Rodriguez, et al.
Investigational New Drugs|January 1, 1994
Phase II trial of trimetrexate in untreated advanced gastric carcinoma. A Southwest Oncology Group studyA Hantel, C M Tangen, J S Macdonald, et al.
Cancer|January 15, 1991
A phase II multi-institutional trial of low-dose N-(phosphonacetyl)-L-aspartate and high-dose 5-fluorouracil as a short-term infusion in the treatment of adenocarcinoma of the pancreas. A Southwest Oncology Group studyL M Morrell, A Bach, S P Richman, et al.
American Journal of Surgery|October 1, 1977
Results of BCG adjuvant immunotherapy in 100 patients with epidermoid carcinoma of the head and neckJ Y Suen, S P Richman, R B Livingston, et al.
Investigational New Drugs|January 1, 1996
Phase II trial of low-dose N-(phosphonacetyl)-disodium L-aspartic acid and high-dose 24-hour infusional 5-fluorouracil in advanced gastric adenocarcinoma. A Southwest Oncology Group studyR L Martino, T R Fleming, L M Morrell, et al.
Cancer|November 1, 1978
Immunotherapy with BCG administered by scarification: standardization of reactions and management of side effectsG N Hortobagyi, S P Richman, K Dandridge, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
World Journal of Surgery|September 1, 1977
Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractionsM A Schwarz, J U Gutterman, E M Hersh, et al.
Cancer|September 15, 1992
Phase II trial of 4'-0-tetrahydropyranyladriamycin (pirarubicin) in head and neck carcinomaK S Sridhar, A M Hussein, P Benedetto, et al.
Cancer Treatment Reports|May 1, 1976
Chemotherapy versus chemoimmunotherapy of head and neck cancer: report of a randomized studyS P Richman, R B Livingston, J U Gutterman, et al.
Cancer Treatment Reports|May 1, 1977
Phase I study of immunotherapy with methanol extraction residue (MER) of bacillus Calmette-GuérinS P Richman, J U Gutterman, E M Hersh, et al.
Cancer|December 1, 1975
Successful control of systemic Aspergillus niger infections in two patients with acute leukemiaF G Gercovich, S P Richman, V Rodriguez, et al.
Investigational New Drugs|January 1, 1994
Phase II trial of trimetrexate in untreated advanced gastric carcinoma. A Southwest Oncology Group studyA Hantel, C M Tangen, J S Macdonald, et al.
Cancer|January 15, 1991
A phase II multi-institutional trial of low-dose N-(phosphonacetyl)-L-aspartate and high-dose 5-fluorouracil as a short-term infusion in the treatment of adenocarcinoma of the pancreas. A Southwest Oncology Group studyL M Morrell, A Bach, S P Richman, et al.
American Journal of Surgery|October 1, 1977
Results of BCG adjuvant immunotherapy in 100 patients with epidermoid carcinoma of the head and neckJ Y Suen, S P Richman, R B Livingston, et al.
Investigational New Drugs|January 1, 1996
Phase II trial of low-dose N-(phosphonacetyl)-disodium L-aspartic acid and high-dose 24-hour infusional 5-fluorouracil in advanced gastric adenocarcinoma. A Southwest Oncology Group studyR L Martino, T R Fleming, L M Morrell, et al.
Cancer|November 1, 1978
Immunotherapy with BCG administered by scarification: standardization of reactions and management of side effectsG N Hortobagyi, S P Richman, K Dandridge, et al.
Pageof 5